Annual EBITDA
-$29.45 M
+$9.06 M+23.53%
December 31, 2022
Summary
- As of February 10, 2025, ANGN annual EBITDA is -$29.45 million, with the most recent change of +$9.06 million (+23.53%) on December 31, 2022.
- During the last 3 years, ANGN annual EBITDA has risen by +$8.65 million (+22.71%).
Performance
ANGN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$4.56 M
-$895.00 K-24.43%
March 31, 2023
Summary
- As of February 10, 2025, ANGN quarterly EBITDA is -$4.56 million, with the most recent change of -$895.00 thousand (-24.43%) on March 31, 2023.
- Over the past year, ANGN quarterly EBITDA has increased by +$9.70 million (+68.02%).
Performance
ANGN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$22.99 M
+$9.70 M+29.67%
March 31, 2023
Summary
- As of February 10, 2025, ANGN TTM EBITDA is -$22.99 million, with the most recent change of +$9.70 million (+29.67%) on March 31, 2023.
- Over the past year, ANGN TTM EBITDA has increased by +$9.99 million (+30.29%).
Performance
ANGN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ANGN EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +23.5% | +68.0% | +30.3% |
3 y3 years | +22.7% | +63.2% | +13.1% |
5 y5 years | -105.3% | +67.6% | -63.5% |
ANGN EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +30.8% | -130.7% | +212.7% | +62.3% | +67.5% |
5 y | 5-year | at high | +85.6% | -130.7% | +334.0% | +63.5% | +191.7% |
alltime | all time | -1281.0% | +85.6% | -130.7% | +334.0% | -1470.2% | +191.7% |
Angion Biomedica EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2023 | - | -$4.56 M(+24.4%) | -$22.99 M(-29.7%) |
Dec 2022 | -$29.45 M(-23.5%) | -$3.66 M(-38.6%) | -$32.69 M(+130.7%) |
Sep 2022 | - | -$5.96 M(-32.3%) | -$14.17 M(-40.3%) |
Jun 2022 | - | -$8.80 M(-38.3%) | -$23.74 M(-28.0%) |
Mar 2022 | - | -$14.26 M(-196.0%) | -$32.98 M(-14.4%) |
Dec 2021 | -$38.51 M(-29.5%) | $14.86 M(-195.6%) | -$38.51 M(-42.6%) |
Sep 2021 | - | -$15.54 M(-13.8%) | -$67.07 M(+6.5%) |
Jun 2021 | - | -$18.04 M(-8.8%) | -$62.97 M(+1.5%) |
Mar 2021 | - | -$19.78 M(+44.4%) | -$62.03 M(+13.5%) |
Dec 2020 | -$54.65 M | -$13.70 M(+19.7%) | -$54.65 M(-0.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2020 | - | -$11.44 M(-33.1%) | -$55.00 M(+26.3%) |
Jun 2020 | - | -$17.10 M(+37.9%) | -$43.55 M(+64.6%) |
Mar 2020 | - | -$12.40 M(-11.8%) | -$26.46 M(+88.2%) |
Dec 2019 | -$38.09 M(+165.7%) | -$14.06 M(<-9900.0%) | -$14.06 M(-5904.3%) |
Dec 2018 | -$14.34 M(-675.2%) | - | - |
Jun 2014 | - | $124.50 K(+5.8%) | $242.20 K(-79.9%) |
Mar 2014 | - | $117.70 K(-89.2%) | $1.21 M(-28.1%) |
Dec 2013 | $2.49 M(+26.9%) | - | - |
Jun 2013 | - | $1.09 M(+84.4%) | $1.68 M(+184.4%) |
Mar 2013 | - | $590.00 K | $590.00 K |
Dec 2012 | $1.96 M | - | - |
FAQ
- What is Angion Biomedica annual EBITDA?
- What is the all time high annual EBITDA for Angion Biomedica?
- What is Angion Biomedica annual EBITDA year-on-year change?
- What is Angion Biomedica quarterly EBITDA?
- What is the all time high quarterly EBITDA for Angion Biomedica?
- What is Angion Biomedica quarterly EBITDA year-on-year change?
- What is Angion Biomedica TTM EBITDA?
- What is the all time high TTM EBITDA for Angion Biomedica?
- What is Angion Biomedica TTM EBITDA year-on-year change?
What is Angion Biomedica annual EBITDA?
The current annual EBITDA of ANGN is -$29.45 M
What is the all time high annual EBITDA for Angion Biomedica?
Angion Biomedica all-time high annual EBITDA is $2.49 M
What is Angion Biomedica annual EBITDA year-on-year change?
Over the past year, ANGN annual EBITDA has changed by +$9.06 M (+23.53%)
What is Angion Biomedica quarterly EBITDA?
The current quarterly EBITDA of ANGN is -$4.56 M
What is the all time high quarterly EBITDA for Angion Biomedica?
Angion Biomedica all-time high quarterly EBITDA is $14.86 M
What is Angion Biomedica quarterly EBITDA year-on-year change?
Over the past year, ANGN quarterly EBITDA has changed by +$9.70 M (+68.02%)
What is Angion Biomedica TTM EBITDA?
The current TTM EBITDA of ANGN is -$22.99 M
What is the all time high TTM EBITDA for Angion Biomedica?
Angion Biomedica all-time high TTM EBITDA is $1.68 M
What is Angion Biomedica TTM EBITDA year-on-year change?
Over the past year, ANGN TTM EBITDA has changed by +$9.99 M (+30.29%)